Can-Fite BioPharma (CANF) Stock Chart & Stock Price History $0.69 -0.01 (-1.14%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$0.69 0.00 (-0.01%) As of 08/8/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Can-Fite BioPharma Stock Price Performance The Can-Fite BioPharma (CANF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 73.77%, with a year-to-date return of -57.72%. In the past month, the stock has decreased 33.61%, reflecting recent market activity. As of the latest close, Can-Fite BioPharma traded at $0.69 with a market cap of $2.43 million and volume of 65,358 shares. Five years ago, the stock traded at a split-adjusted price of $22.20, representing a 96.90% decrease over that period. At the time, it had a market cap of $38.38 million and a volume of 55,301 shares. Receive CANF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.64%1 Month Performance-33.61%3 Month Performance-38.10%Year-To-Date Performance-57.72%1 Year Performance-73.77%5 Year Performance-96.90% CANF Stock Chart for Sunday, August, 10, 2025 CANF Chart by TradingView Can-Fite BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$0.70$0.69-1.14%$0.70$0.6865,358 shs$2.43 million08/07/2025$0.69$0.70+1.40%$0.70$0.69120,244 shs$2.46 million08/06/2025$0.69$0.69-0.88%$0.70$0.68157,555 shs$2.43 million08/05/2025$0.67$0.69+2.52%$0.70$0.67126,693 shs$2.45 million08/04/2025$0.66$0.67+2.74%$0.69$0.6783,287 shs$2.39 million08/01/2025$0.67$0.66-2.00%$0.67$0.63244,627 shs$2.32 million07/31/2025$0.68$0.67-0.90%$0.68$0.66117,069 shs$2.37 million07/30/2025$0.71$0.68-5.26%$0.71$0.66489,055 shs$2.39 million07/29/2025$0.70$0.71+1.73%$0.73$0.67496,174 shs$2.53 million07/28/2025$0.98$0.70-28.43%$1.00$0.693.33 million shs$2.48 million Get the Latest News and Ratings for CANF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$1.01$0.98-2.97%$1.01$0.97231,228 shs$3.47 million07/24/2025$1.04$1.01-2.42%$1.04$0.99520,693 shs$3.58 million07/23/2025$1.03$1.04+0.98%$1.05$1.03103,518 shs$3.66 million07/22/2025$1.04$1.03-0.97%$1.04$1.0251,517 shs$3.63 million07/21/2025$1.04$1.04$1.05$1.0244,419 shs$3.66 million07/18/2025$1.05$1.04-0.96%$1.05$1.0337,016 shs$3.66 million07/17/2025$1.05$1.05$1.05$1.04105,456 shs$3.70 million07/16/2025$1.05$1.05$1.05$1.0433,126 shs$3.70 million07/15/2025$1.03$1.05+1.06%$1.05$1.0364,790 shs$3.70 million07/14/2025$1.04$1.03-0.10%$1.04$1.0299,109 shs$3.66 million07/11/2025$1.04$1.04$1.05$1.0231,778 shs$3.66 million07/10/2025$1.03$1.04+0.49%$1.04$1.0334,903 shs$3.66 million07/09/2025$1.03$1.03$1.04$1.0234,201 shs$3.65 million Related Companies Acurx Pharmaceuticals Stock Price Chart Dogwood Therapeutics Stock Price Chart X4 Pharmaceuticals Stock Price Chart Aprea Therapeutics Stock Price Chart Soligenix Stock Price Chart Sonnet BioTherapeutics Stock Price Chart Chromocell Therapeutics Stock Price Chart Addex Therapeutics Stock Price Chart Cellectar Biosciences Stock Price Chart Cyclerion Therapeutics Stock Price Chart Receive CANF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CANF) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can-Fite BioPharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can-Fite BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
